Clinical Trial Update: Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating nebulised colistimethate sodium to prevent ventilator-associated pneumonia in pediatric patients is currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• colistimethate sodium (nebulised) (colistimethate sodium)

Snippet

Sponsor: University Hospital Fattouma Bourguiba | Conditions: Ventilator Associated Pneumonia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING